Emergent Biosolutions Inc. sell JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€1.86
Target price
20.11.24
-
Performance (%)
-3.41%
Price
26.04.24
€1.80
Summary
This prediction is currently active. With a performance of -3.41%, the SELL prediction for Emergent Biosolutions Inc. by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 20.11.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Emergent Biosolutions Inc. | -5.785% | -5.785% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Ratings data for EBS provided by MarketBeat